Beta-Blocker Market to Reach USD 7.2 Bn by 2031 as Next-Gen Formulations Address Adherence Challenges
[Basel, Switzerland, April 23rd, 2025] – The global beta-blocker market, valued at 4.8 billion in 2023, is projected to grow at 5.2% to 7.2 billion by 2031, according to ClearView Market Insights. Innovations in extended-release formulations and transdermal delivery systems are transforming this essential drug class.
Request Sample @...
0
0
36
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek